Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
Authors:
- Yuka AokiYAYuka Aoki
- Masanori NojimaMNMasanori Nojima
- Hiromu SuzukiHSHiromu Suzuki
- Hiroshi YasuiHYHiroshi Yasui
- Reo MaruyamaRMReo Maruyama
- Eiichiro YamamotoEYEiichiro Yamamoto
- Masami AshidaMAMasami Ashida
- Mitsuhiro ItagakiMIMitsuhiro Itagaki
- Hideki AsaokuHAHideki Asaoku
- Hiroshi IkedaHIHiroshi Ikeda
- Kohzoh ImaiKIKohzoh Imai
Open Access
- 22 December 2012
- journal article
- research article
- Published by Springer Nature in Genome Medicine
- Vol. 4 (12) , 101
Abstract
Background: The aim of this study was to clarify the role of global hypomethylation of repetitive elements in determining the genetic and clinical features of multiple myeloma (MM). Methods: We assessed global methylation levels using four repetitive elements (long interspersed nuclear element-1 (LINE-1), Alu Ya5, Alu Yb8, and Satellite-α) in clinical samples comprising 74 MM samples and 11 benign control samples (7 cases of monoclonal gammopathy of undetermined significance (MGUS) and 4 samples of normal plasma cells (NPC)). We also evaluated copy-number alterations using array-based comparative genomic hybridization, and performed methyl-CpG binding domain sequencing (MBD-seq). Results: Global levels of the repetitive-element methylation declined with the degree of malignancy of plasma cells (NPC>MGUS>MM), and there was a significant inverse correlation between the degree of genomic loss and the LINE-1 methylation levels. We identified 80 genomic loci as common breakpoints (CBPs) around commonly lost regions, which were significantly associated with increased LINE-1 densities. MBD-seq analysis revealed that average DNA-methylation levels at the CBP loci and relative methylation levels in regions with higher LINE-1 densities also declined during the development of MM. We confirmed that levels of methylation of the 5' untranslated region of respective LINE-1 loci correlated strongly with global LINE-1 methylation levels. Finally, there was a significant association between LINE-1 hypomethylation and poorer overall survival (hazard ratio 2.8, P = 0.015). Conclusion: Global hypomethylation of LINE-1 is associated with the progression of and poorer prognosis for MM, possibly due to frequent copy-number loss.Keywords
This publication has 50 references indexed in Scilit:
- A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBlood, 2010
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeBlood, 2007
- Recent Advances in the Treatment of Multiple MyelomaCurrent Pharmaceutical Biotechnology, 2006
- The molecular classification of multiple myelomaBlood, 2006
- Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implicationsBlood, 2006
- High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsCancer Cell, 2006
- Advances in biology of multiple myeloma: clinical applicationsBlood, 2004
- Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationBlood, 2002
- p16 INK4a andp15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significanceBlood, 2001
- Frequent Hypermethylation of p16 and p15 Genes in Multiple MyelomaBlood, 1997